Clinical trial
The Use of Low Molecular Weight Heparin in Traumatic Brain Injury
NCT00170378 · Hennepin Healthcare Research Institute, Other · Completed
Key facts
| NCT number | NCT00170378 |
|---|---|
| Title | The Use of Low Molecular Weight Heparin in Traumatic Brain Injury |
| Official title | The Use of Low Molecular Weight Heparin in Traumatic Brain Injury |
| Lead sponsor | Hennepin Healthcare Research Institute, Other |
| Collaborators | Aventis Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Brain Injury, Venous Thrombosis |
| Intervention type | Drug |
| Interventions | Enoxaparin |
| Enrollment | 300 |
| Start date | Dec 1, 2002 |
| Completion | Aug 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Jun 27, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: